FOOD & BEVERAGE
Global Human Milk Oligosaccharides Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Human Milk Oligosaccharides Market, By Type (2’FL, 3’FL, 3’SL, 6’SL), Product (Fucosyllactose, Lnt & LNnt, Sialyllactose), Concentration (Neutral HMO and Acidic HMO), Application (Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal, Other), Distribution channel (Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores, Online sales channel), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global human milk oligosaccharides market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Human Milk Oligosaccharides (HMOs) are complex carbohydrates found in human breast milk that include a variety of forms that newborns cannot digest yet serve important roles. They function as prebiotics, promoting the growth of healthy gut bacteria, boosting the immune system, and protecting newborns from harmful germs. HMOs are specific to human milk and not found in newborn formula. Human milk oligosaccharides market includes the manufacture and commercialization of HMOs and their derivatives. This market is driven by the growing need for better newborn nutrition and intestinal health and involves the synthesis of HMOs for use in functional foods and infant formulas. To meet the needs of a rising market concerned with maternity and infant health, major manufacturers concentrate on innovation in HMO formulations and applications.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rising birth rates and growing population of infants.
- Increased focus on enhancing infant gut health and immunity.
RESTRAINTS
- High cost of HMO production.
- Limited availability of raw materials.
OPPORTUNITIES
- Growing market for personalized nutrition and supplements.
- Emerging markets with rising disposable incomes.
CHALLENGES
- High production costs and technical complexities.
- Regulatory challenges in different regions.
SEGMENTATION
- Type
- 2’FL
- 3’FL
- 3’SL
- 6’SL
- Product
- Fucosyllactose
- Lnt & LNnt
- Sialyllactose
- Concentration
- Neutral HMO
- Acidic HMO
- Application
- Infant formula
- Functional food & beverages
- Food supplements
- Health ingredients for human and animal
- Other
- Distribution channel
- Hypermarkets and supermarkets
- Drug store or pharmacy
- Mass merchandiser
- Departmental stores
- Mono-brand stores
- Specialty stores
- Online sales channel
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- ZuChem Inc.
- Elicityl SA
- Jennewein Biotechnologie GmbH
- Royal FrieslandCampina NV
- BASF SE
- Gnubiotics
- DuPont Nutrition & Health
- Inbiose NV
- Glycom A/S
- Glycosyn LLC
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Human Milk Oligosaccharides Market, by Type
- 3.2 Global Human Milk Oligosaccharides Market, by Product
- 3.3 Global Human Milk Oligosaccharides Market, by Concentration
- 3.4 Global Human Milk Oligosaccharides Market, by Application
- 3.5 Global Human Milk Oligosaccharides Market, by Distribution channel
- 3.6 Global Human Milk Oligosaccharides Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Rising demand for advanced infant formula products.
- 5.1.2 Technological advancements in HMO production.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising birth rates and growing population of infants.
- 5.2.2 Increased focus on enhancing infant gut health and immunity.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of HMO production.
- 5.3.2 Limited availability of raw materials.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Growing market for personalized nutrition and supplements.
- 5.4.2 Emerging markets with rising disposable incomes.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 High production costs and technical complexities.
- 5.5.2 Regulatory challenges in different regions.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Human Milk Oligosaccharides Market, by Type (2019-2032)
- SECTION 7 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY PRODUCT
- 7.1 Product Summary
- 7.2 Market Attractive Index
- 7.3 Global Human Milk Oligosaccharides Market, by Product (2019-2032)
- SECTION 8 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION
- 8.1 Concentration Summary
- 8.2 Market Attractive Index
- 8.3 Global Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- SECTION 9 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global Human Milk Oligosaccharides Market, by Application (2019-2032)
- SECTION 10 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY DISTRIBUTION CHANNEL
- 10.1 Distribution channel Summary
- 10.2 Market Attractive Index
- 10.3 Global Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- SECTION 11 - GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Human Milk Oligosaccharides Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Human Milk Oligosaccharides Market, by Type (2019-2032)
- 12.4 North America Human Milk Oligosaccharides Market, by Product (2019-2032)
- 12.5 North America Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- 12.6 North America Human Milk Oligosaccharides Market, by Application (2019-2032)
- 12.7 North America Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- 12.8 North America Human Milk Oligosaccharides Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE HUMAN MILK OLIGOSACCHARIDES MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Human Milk Oligosaccharides Market, by Type (2019-2032)
- 13.4 Europe Human Milk Oligosaccharides Market, by Product (2019-2032)
- 13.5 Europe Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- 13.6 Europe Human Milk Oligosaccharides Market, by Application (2019-2032)
- 13.7 Europe Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- 13.8 Europe Human Milk Oligosaccharides Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Human Milk Oligosaccharides Market, by Type (2019-2032)
- 14.4 Asia-Pacific Human Milk Oligosaccharides Market, by Product (2019-2032)
- 14.5 Asia-Pacific Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- 14.6 Asia-Pacific Human Milk Oligosaccharides Market, by Application (2019-2032)
- 14.7 Asia-Pacific Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- 14.8 Asia-Pacific Human Milk Oligosaccharides Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA HUMAN MILK OLIGOSACCHARIDES MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Human Milk Oligosaccharides Market, by Type (2019-2032)
- 15.4 South America Human Milk Oligosaccharides Market, by Product (2019-2032)
- 15.5 South America Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- 15.6 South America Human Milk Oligosaccharides Market, by Application (2019-2032)
- 15.7 South America Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- 15.8 South America Human Milk Oligosaccharides Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Human Milk Oligosaccharides Market, by Type (2019-2032)
- 16.4 Middle East and Africa Human Milk Oligosaccharides Market, by Product (2019-2032)
- 16.5 Middle East and Africa Human Milk Oligosaccharides Market, by Concentration (2019-2032)
- 16.6 Middle East and Africa Human Milk Oligosaccharides Market, by Application (2019-2032)
- 16.7 Middle East and Africa Human Milk Oligosaccharides Market, by Distribution channel (2019-2032)
- 16.8 Middle East and Africa Human Milk Oligosaccharides Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Human Milk Oligosaccharides Market, Company Share Analysis
- 17.2 North America Human Milk Oligosaccharides Market, Company Share Analysis
- 17.3 Europe Human Milk Oligosaccharides Market, Company Share Analysis
- 17.4 Asia-Pacific Human Milk Oligosaccharides Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 ZuChem Inc.
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Elicityl SA
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Jennewein Biotechnologie GmbH
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 Royal FrieslandCampina NV
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 BASF SE
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Gnubiotics
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 DuPont Nutrition & Health
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 Inbiose NV
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Glycom A/S
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Glycosyn LLC
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.